Navigation Links
The AACR commends Senators Kennedy and Hutchison on the 21st Century Cancer ALERT Act
Date:3/26/2009

PHILADELPHIA ― On Thursday, Senators Edward M. Kennedy and Kay Bailey Hutchison introduced legislation that will renew the war on cancer by modernizing and advancing the national cancer program of the United States.

The 21st Century Cancer ALERT (Access to Life-saving Early detection, Research and Treatment) Act represents an important effort to re-assess the national cancer program and improve cancer research, prevention, detection, control and treatment in the United States. The legislation aims to expand and accelerate the search for cures, more effective treatments and better preventive measures while addressing the ongoing needs of the nearly 12 million Americans struggling with cancer today.

"It is imperative that we move with greater speed to strengthen and expand our nation's efforts to prevent, treat and cure cancer," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the American Association for Cancer Research. "The leadership that Senators Kennedy and Hutchison are providing comes at a pivotal moment, when decades of scientific effort are converging to produce a revolution in cancer research and care. The 21st Century Cancer ALERT Act represents a critical step in modernizing the national cancer program and in improving our ability to make headway in the war on cancer."

Since the United States declared war on cancer over four decades ago with the signing of National Cancer Act of 1971, tremendous strides have been made in the understanding of the disease and in the development of therapies that have increased survival and improved the lives of millions. Despite these accomplishments, cancer still kills more than 560,000 Americans each year. Without a greater commitment to cancer research, this number will increase as the baby boom generation grows older. In fact, by 2010, cancer will be the world's number one killer, according to the World Health Organization.

In their endeavor to address the complexities and obstacles confronting the national cancer program, Senators Kennedy and Hutchison have sought input from stakeholders representing every aspect of cancer research and care from the bench to bedside. The AACR applauds their leadership in engaging a wide range of experts to identify key challenges and craft legislation that presents solutions that will foster a new age of discovery and patient care.

"The AACR has been grateful for the opportunity to contribute its expertise in cancer research to this undertaking," said Ray DuBois, M.D., Ph.D., president of the American Association for Cancer Research and provost and executive vice president of The University of Texas M. D. Anderson Cancer Center. "We look forward to working closely with Senators Kennedy and Hutchison to refine this legislation and advance it quickly through Congress for the benefit of cancer patients and their families."


'/>"/>

Contact: Jeremy Moore
Jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Frost & Sullivan Commends Nycomed for Excellence in Product Differentiation Innovation
2. Illinois Hospital Association Commends Governor for Protecting Health Care in State Budget Proposal
3. The National Kidney Foundation of Florida Commends Senator Thad Altman, Representative Ritch Workman for Co-Sponsoring Common Sense Legislation Widely Hailed as Good for Patients, Good for Taxpayers, Good for Florida
4. Virtua Commends Gov. Corzines Charity Care Funding Plan
5. National Multiple Sclerosis Society Commends President Obamas Initial Steps in Removing the Bans on Embryonic Stem Cell Research
6. Christopher & Dana Reeve Foundation Commends President Obamas Decision to Lift Federal Restrictions on Stem Cell Research
7. Save Abandoned Babies Foundation Commends Illinois Hospitals for Being 100% in Compliance in Displaying Safe Haven Signs
8. Leading Proxy Advisory Firm RiskMetrics Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group
9. NACDS Commends Obama's Shared Commitment on Accessible, Quality and Affordable Healthcare
10. Himfr.com Recommends Five Foods for Spring
11. Glass Lewis Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Three Proposals by Dissident Joffe Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... ... and accessories. These PEEK-lined stainless steel (PLS) columns combine the strength of traditional ... ensures the integrity of biological samples while operating at ultra-high pressures of 20,000 ...
(Date:2/10/2016)... ... February 10, 2016 , ... Anxiety of older Americans over steep cost ... Part D a decade ago, according to The Senior Citizens League (TSCL). ... they are coping with rapidly rising costs. “The implications are chilling, particularly for ...
(Date:2/10/2016)... ... February 09, 2016 , ... Traumatic Brian Injury ... injury may be one of many possible sources: sports, car accidents, falls, work ... , Mastering Rehab Solutions for the Complexities of Concussions is designed ...
(Date:2/9/2016)... ... February 09, 2016 , ... February is Heart Awareness Month, and ... scans throughout the month to the American Heart Association, New Mexico chapter. , A ... heart disease and Health Quest’s INSiGHT Pulse Wave Profiler utilizes a non-invasive technology to ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... announces today the continuation of the ‘Pay It Forward’ program into 2016. BioPlus ... received at our specialty pharmacy. , “Since our Pay It Forward program ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 2016 --> ... and Companion Diagnostic Market to 2019 - Strategic ... research report indicates that the core personalized medicine ... 2020 growing at a CAGR of 8.74%. This ... targeted therapeutics and is dominated by oncology, cardiovascular ...
(Date:2/10/2016)... , February 10, 2016 ... M 1 receptor selectivity   ... technology, which has entered clinical development as a ... dementia and schizophrenia.   --> 1 ... which has entered clinical development as a new ...
(Date:2/9/2016)... 9, 2016  Misonix, Inc. (NASDAQ: MSON ... manufactures and markets innovative therapeutic ultrasonic products for ... surgery, laparoscopic surgery and other surgical applications, today ... the first half of fiscal year 2016 ended ... --> Highlights for the second ...
Breaking Medicine Technology: